Literature DB >> 21589341

Chlorido[4-(pyridin-2-yl-κN)pyrimidine-2-sulfonato-κN,O]palladium(II).

Hai-Bin Zhu, Xian-Shan Hou.   

Abstract

In the title compound, [Pd(C(9)H(6)N(3)O(3)S)Cl], the Pd(II) ion is coordinated by one O and two N atoms from a 4-(pyridin-2-yl)pyrimidine-2-sulfonate ligand and one chloride anion in a distorted square-planar geometry. In the crystal, all mol-ecules are situated on mirror planes and inter-act through weak inter-molecular C-H⋯O hydrogen bonds.

Entities:  

Year:  2010        PMID: 21589341      PMCID: PMC3011378          DOI: 10.1107/S1600536810049184

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


  3 in total

1.  Current status of platinum-based antitumor drugs.

Authors:  E Wong; C M Giandomenico
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 3.  Recent advances involving palladium (II) complexes for the cancer therapy.

Authors:  Antonio Carlos Favero Caires
Journal:  Anticancer Agents Med Chem       Date:  2007-09       Impact factor: 2.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.